Production of peptides as generic drugs: a patent landscape of octreotide

References

• Agyei D, Danquah MK. Industrial-scale manufacturing of pharmaceutical-grade bioactive peptides. Biotechnol Adv. 2011;29:272–277.
   PubMed Web of Science ®Google Scholar
• Hartmann R, Meisel H. Food-derived peptides with biological activity: from research to food applications. Curr Opin Biotechnol. 2007;18:163–169.
   PubMed Web of Science ®Google Scholar
• Zambrowicz A, Timmer M, Polanowski A, et al. Manufacturing of peptides exhibiting biological activity. Amino Acids. 2013;44:315–320.
   PubMed Web of Science ®Google Scholar
• Nestor JJ Jr. The medicinal chemistry of peptides. Curr Med Chem. 2009;16:4399–4418.
   PubMed Web of Science ®Google Scholar
• Frost & Sullivan.2004. [cited 2015 Nov 13]. Avalaible from: http://www.pharmamanufacturing.com/assets/Media/PublicationsArticle/Peptide.pdf
   Google Scholar
• Fosgerau K, Hoffmann T. Peptide therapeutics: current status and future directions. Drug Discov Today. 2015;20:122–128.
   PubMed Web of Science ®Google Scholar
• Kolesińska B, Frączyk J, Sabatino G, et al. Sulfonates of N-triazinylammonium salts as highly efficient, inexpensive and environmentally friendly coupling reagents for peptide synthesis of as highly efficient. Chem Today. 2007;25(1):10–13.
   Google Scholar
• Hojo K, Hara A, Kitai H. Development of a method for environmentally friendly chemical peptide synthesis in water using water-dispersible amino acid nanoparticles. Chem Cent J. 2011;5:49.
   PubMedGoogle Scholar
• Hojo K, Maeda M, Kawasaki K. Solid-phase peptide synthesis in water. III. A water-soluble N-protecting group, 2-[phenyl(methyl)sulfonio]ethoxycarbonyl tetrafluoroborate, and its application to peptide synthesis. Tetrahedron. 2004;60:1875–1866.
   Web of Science ®Google Scholar
• Goodwin D, Simerska P, Toth I. Peptides as therapeutics with enhanced bioactivity. Curr Med Chem. 2012;19:4451–4461.
   PubMed Web of Science ®Google Scholar
• Rupp S. Next-generation bioproduction systems: cell-free conversion concepts for industrial biotechnology. Eng Life Sci. 2013;13:19–25.
   Web of Science ®Google Scholar
• Albericio F, Kruger HG. Therapeutic peptides. Future Med Chem. 2012;4:1527–1531.
   PubMed Web of Science ®Google Scholar
• Bray BL. Large-scale manufacture of peptide therapeutics by chemical synthesis. Nat Rev Drug Discov. 2003;2:587–593.
   PubMed Web of Science ®Google Scholar
• Benoiton NL. 2-Alkoxy-5(4H)-oxazolones and the enantiomerization of N-alkoxycarbonylamino acids. Biopolymers. 1996;40:245–254.
   Web of Science ®Google Scholar
• Sabatino G, Chelli M, Brandi A, et al. Curr Org Chem. 2004;8:291–301.
   Google Scholar
• Sabatino G, Papini AM. Advances in automatic, manual and microwave-assisted solid-phase peptide synthesis. Curr Opin Drug Discov Devel. 2008;11:762–770.
   PubMed Web of Science ®Google Scholar
• Albericio F. Developments in peptide and amide synthesis. Curr Opin Chem Biol. 2004;8:211–221.
   PubMed Web of Science ®Google Scholar
• Albericio F, Carpino LA. Coupling reagents and activation. Method Enzymol. 1997;289:104–126.
   PubMed Web of Science ®Google Scholar
• Han S-Y, Kim Y-A. Recent development of peptide coupling reagents in organic synthesis. Tetrahedron. 2004;60:2447–2467.
   Web of Science ®Google Scholar
• Al-Warhi TI, Al-Hazimi HMA, ElFaham A. Recent development in peptide coupling reagents. J Saudi Chem Soc. 2012;16:97–116.
   Web of Science ®Google Scholar
• Sabatino G, Mulinacci B, Alcaro MC, et al. Assessment of new 6Cl-HOBt based coupling reagents for peptide synthesis. Part 1: coupling efficiency study. Lett Pept Sci. 2002;9:119–123.
   Google Scholar
• Kamiński ZJ, Kolesińska B, Kolesińska J, et al. N-triazinylammonium tetrafluoroborates. A new generation of efficient coupling reagents useful for peptide synthesis. J Am Chem Soc. 2005;127:16912–16920.
   PubMed Web of Science ®Google Scholar
• Jastrząbek K, Kolesińska B, Sabatino G, et al. Benzyloxy derivatives of triazine-based coupling reagents designed for an efficient solid phase peptide synthesis on polystyrene resin. Int J Pept Res Ther. 2007;13:229–236.
   Web of Science ®Google Scholar
• Rizzolo F, Sabatino G, Chelli M, et al. A convenient microwave-enhanced solid-phase synthesis of difficult peptide sequences: case study of Gramicidin A and CSF114(Glc). Int J Pept ResTher. 2007;13:203–208.
   Web of Science ®Google Scholar
• Uhlig T, Kyprianou T, Martinelli FG, et al. The emergence of peptides in the pharmaceutical business: from exploration to exploitation. EuPA Open Proteom. 2014;4:58–69.
   Google Scholar
• Sevarino KA, Felix R, Banks CM, et al. Cell-specific processing of preprosomatostatin in cultured neuroendocrine cells. J Biol Chem. 1987;262:4987–4993.
   PubMed Web of Science ®Google Scholar
• Benoit R, Esch F, Bennett HP, et al. Processing of prosomatostatin. Metabolism. 1990;39:22–25.
   PubMed Web of Science ®Google Scholar
• Rivier JE. Somatostatin. Total solid phase synthesis. J Am Chem Soc. 1974;96:2986–2992.
   PubMed Web of Science ®Google Scholar
• Burgus R, Ling N, Butcher M, et al. Primary structure of somatostatin, a hypothalamic peptide that inhibits the secretion of pituitary growth hormone. Proc Natl Acad Sci USA. 1973;70:684–688.
   PubMed Web of Science ®Google Scholar
• Pradayrol L, Jörnvall H, Mutt V, et al. N-terminally extended somatostatin: the primary structure of somatostatin-28. FEBS Lett. 1980;109:55–58.
   PubMed Web of Science ®Google Scholar
• Guillemin R. Peptides in the brain: the new endocrinology of the neuron. Science. 1978;202:390–402.
   PubMed Web of Science ®Google Scholar
• Reichlin S. Somatostatin. N Engl J Med. 1983;309:1495–1501.
   PubMed Web of Science ®Google Scholar
• Reichlin S. Somatostatin (second of two parts). N Engl J Med. 1983;309:1556–1563.
   PubMed Web of Science ®Google Scholar
• Lewin MJ. The somatostatin receptor in the GI tract. Annu Rev Physiol. 1992;54:455–468.
   PubMed Web of Science ®Google Scholar
• Epelbaum J. Somatostatin in the central nervous system: physiology and pathological modifications. Prog Neurobiol. 1986;27:63–100.
   PubMed Web of Science ®Google Scholar
• Epelbaum J, Dournaud P, Fodor M, et al. The neurobiology of somatostatin. Crit Rev Neurobiol. 1994;8:25–44.
   PubMedGoogle Scholar
• Yamada Y, Post SR, Wang K, et al. Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract and kidney. Proc Natl Acad Sci USA. 1992;89:251–255.
   PubMed Web of Science ®Google Scholar
• Patel YC. Somatostatin and its receptor family. Front Neuroendocrinol. 1999;20:157–198.
   PubMed Web of Science ®Google Scholar
• Weckbecker G, Lewis I, Albert R, et al. Opportunities in somatostatin research: biological, chemical and therapeutic aspects. Nat Rev Drug Discov. 2003;2:999–1017.
   PubMed Web of Science ®Google Scholar
• Patel YC, Srikant CB. Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors (hsstr 1-5). Endocrinology. 1994;135:2814–2817.
   PubMed Web of Science ®Google Scholar
• Reubi JC, Schaer JC, Waser B, et al. Expression and localization of somatostatin receptor SSTR1, SSTR2, and SSTR3 messenger RNAs in primary human tumors using in situ hybridization. Cancer Res. 1994;54:3455–3459.
   PubMed Web of Science ®Google Scholar
• Reubi JC, Waser B, Schaer JC, et al. Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands. Eur J Nucl Med. 2001;28:836–846.
   PubMedGoogle Scholar
• Lamberts SW, Van Der Lely AJ, De Herder WW, et al. Octreotide. N Engl J Med. 1996;334:246–254.
   PubMed Web of Science ®Google Scholar
• Veber DF, Freidinger RM, Perlow DS, et al. A potent cyclic hexapeptide analogue of somatostatin. Nature. 1981;292:55–58.
   PubMed Web of Science ®Google Scholar
• Brady SF, Freidinger RM, Paleveda WJ, et al Large-scale synthesis of a cyclic hexapeptide analogue of somatostatin. J Org Chem. 1987;52:764–769.
   Web of Science ®Google Scholar
• Freidinger RM. Design and synthesis of novel bioactive peptides and peptidomimetics. J Med Chem. 2003;46(26):5553–5566.
   PubMed Web of Science ®Google Scholar
• Janecka A, Zubrzycka M, Janecki T. Somatostatin analogs. J Pept Res. 2001;58:91–107.
   PubMedGoogle Scholar
• Pless J. The history of somatostatin analogs. J Endocrinol Invest. 2005;28:1–4.
   PubMedGoogle Scholar
• Veber DF, Saperstein R, Nutt RF, et al A super active cyclic hexapeptide analog of somatostatin. Life Sci. 1984;34:1371–1378.
   PubMed Web of Science ®Google Scholar
• Freidinger RM, Paleveda WJ, Colton CD, et al. Large-scale synthesis of a cyclic hexapeptide analogue of somatostatin. J Org Chem. 1987;52:764–769.
   Web of Science ®Google Scholar
• Lewis I, Bauer W, Albert R, et al A novel somatostatin mimic with broad somatotropin release inhibitory factor receptor binding and superior therapeutic potential. J Med Chem. 2003;46:2334–2344.
   PubMed Web of Science ®Google Scholar
• Weckbecker G, Lewis I, Albert R, et al Oppurtinities in somatostatin research: biological and therapeutic aspects. Nat Review Drug Discov. 2003;2:999–1017.
   PubMed Web of Science ®Google Scholar
• Bauer W, Briner U, Doepfner W, et al. SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci. 1982;31:1133–1140.
   PubMed Web of Science ®Google Scholar
• Marbach P, Briner U, Lemaire M, et al. From somatostatin to sandostatin: pharmacodynamics and pharmacokinetics. Metabolism. 1992;41:7–10.
   PubMed Web of Science ®Google Scholar
• Reubi JC, Schär JC, Waser B, et al. Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use. Eur J Nucl Med. 2000;27:273–282.
   PubMedGoogle Scholar
• Deghenghi R, Papotti M, Ghigo E, et al Somatostatin octapeptides (lanreotide, octreotide, vapreotide, and their analogs) share the growth hormone–releasing peptide receptor in the human pituitary gland. Endocrine. 2001;14(1):29–33.
   PubMed Web of Science ®Google Scholar
• Fields GB, Tian Z, Barany G. Principles and practice of solid-phase peptide synthesis. In: Grant GA, ed. Synthetic peptides: A user’s guide. New York: Freeman WH & Co; 1992.
   Google Scholar
• Marbach P, Bauer W, Bodmer D, et al. Discovery and development of somatostatin agonists. In: Borchardt RT, Freidinger RM, Sawyer TK, et al. editors. Integration of pharmaceutical discovery and development: case histories. New York: Kluwer; 2002. p. 183–205.
   Google Scholar
• Neugebauer W, Escher E. Solid-phase synthesis of C-terminal peptide amino alcohols. Helv Chim Acta. 1989;72:1319–1323.
   Web of Science ®Google Scholar
• Neugebauer W, Lefevre MR, Laprise R, et al. Peptides: chemistry, structure and biology. Marshal GR, Rivier JE, eds. Leiden: ESCOM; 1990.
   Google Scholar
• Mergler M, Hellstern H, Wirth W, et al. A. new acid-labile linker for the solid-phase synthesis of peptides with C-terminal threoninol. In abstracts of the twelfth american peptide symposium, june 16-21,1991, Boston, MA. Cambridge: Massachusetts Institute of Technology; 1991. p. P–292.
   Google Scholar
• Mergler M, Nyfeler R. Rapid synthesis of fully protected peptide alcohols. Peptides 1992. Schneider CH, Eberle AN, eds. Leiden: ESCOM; 1993.
   Google Scholar
• Edwards WB, Fields CG, Anderson CJ, et al. Generally applicable, convenient solid-phase synthesis and receptor affinities of octreotide analogs. J Med Chem. 1994;37:3749–3757.
   PubMed Web of Science ®Google Scholar
• Wenschuh H, Beyermann M, Haber H, et al. Stepwise automated solid phase synthesis of naturally occurring peptaibols using Fmoc amino acid fluorides. J Org Chem. 1995;60:405–410.
   Web of Science ®Google Scholar
• Barlos K, Gatos D, Kallitsis J, et al. Darstellung geschützter peptid-fragmente unter einsatz substituierter triphenylmethyl-harze. Tetrahedron Lett. 1989;30:3943–3946.
   Google Scholar
• Arano Y, Akizawa H, Uezono T, et al. Conventional and high-yield synthesis of DTPA-conjugated peptides: application of a monoreactive DTPA to DTPA-D-Phe1-octreotide synthesis. Bioconjug Chem. 1997;8:442–446.
   PubMed Web of Science ®Google Scholar
• Institute of Nuclear Energy Research, Taiwan Hsieh YT, Chang SR, Chyi SY, et al. Process for preparing octreotide and derivatives thereof US 6476186. 2002
   Google Scholar
• Teva Pharmaceuticals USA Tovi A, Eidelman C, Shushan S, et al. Process for production of cyclic peptides. WO2004092202. 2004.
   Google Scholar
• Schmidt MA, Wilhelm RR, Srinivasan A. In Abstracts of the fifteenth american peptide symposium. Nashville. Nashville (TN): American Peptide Society; p. 2–109. 1997 June 14–19.
   Google Scholar
• Alsina J, Chiva C, Ortiz M, et al. Active carbonate resins for solid-phase synthesis through the anchoring of a hydroxyl function. Synthesis of cyclic and alcohol peptides. Tetrahedron Lett. 1997;38:883–886.
   Web of Science ®Google Scholar
• Zheng A, Shan D, Wang B. A redox-sensitive resin linker for the solid phase synthesis of C-terminal modified peptides. J Org Chem. 1999;64:156–161.
   PubMed Web of Science ®Google Scholar
• Mergler M, Dick F, Gosteli J, et al. Solid phase synthesis of fully protected peptide alcohols. Tetrahedron Lett. 1999;40:4663–4664.
   Web of Science ®Google Scholar
• Wu Y-T, Hsieh H-P, Wu C-Y, et al. Facile solid phase synthesis of octreotide analogs using p-carboxybenzaldehyde as a novel linker to anchor Fmoc-threoninol to solid phase resins. Tetrahedron Lett. 1998;39:1783–1784.
   Web of Science ®Google Scholar
• Hsieh HP, Wu YT, Chen ST, et al. Direct solid-phase synthesis of octreotide conjugates: precursors for use as tumor-targeted radiopharmaceuticals. Bioorg Med Chem. 1999;7:1797–1803.
   PubMed Web of Science ®Google Scholar
• Institute of Nuclear Energy Research, TaiwanLee TW, Chen ST, Chang SR, et al. Synthesis of bifunctional chelating agents-peptides. US5889146. 1999.
   Google Scholar
• Carotenuto A, D ‘Addona D, Rivalta E, et al. Synthesis of a dicarba-analog of octreotide keeping the type II’ β-turn of the pharmacophore in water solution. Lett Org Chem. 2005;2:274–279.
   Web of Science ®Google Scholar
• D’Addona D, Carotenuto A, Novellino E, et al. Novel sst5-selective somatostatin dicarba-analogues: synthesis and conformation-affinity relationships. J Med Chem. 2008;51:512–520.
   PubMed Web of Science ®Google Scholar
• Lipotec SA, SpainClemente Rodriguez FJ, Ponsati Obiols B, et al. Procedure for obtaining the somatostatin analog octreotide. EP0953577 1999 and US6346601. 2002.
   Google Scholar
• Roux S, et al. Elimination and exchange of trifluoroacetate counter-ion from cationic peptides: a critical evaluation of different approaches. J Pept Sci. 2008;14:354–359.
   PubMed Web of Science ®Google Scholar
• Sandoz Ltd, SwitzerlandBauer W, Pless J Novel polypeptides, processes for their production, pharmaceutical compositions comprising said polypeptides and their use. US4395403 EP0029579. 1983.
   Google Scholar
• Sandoz Ltd, SwitzerlandRainer A, Bauer W, Cardinaux F et al. Synthesis of peptide alcohols. GB2233652. 1991.
   Google Scholar
• Institute of Nuclear Energy Research, TaiwanLee TW, Chen ST, Chang SR, et al. Synthesis of bifunctional chelating agents-peptides. US5889146. 1999.
   Google Scholar
• Samukov VV, Pozdnjakov PI Synthesis in solution of octreotide using various protective groups for improved synthesis. RU 2196144. 2001.
   Google Scholar
• Inst. of Toxic Drugs, Academy of Military Medical Sciences, PLA, Peop. Rep. ChinaLiu K, Liang Y, Li B. et al. Liquid phase synthesis of octreotide acetate. CN1355173. 2002.
   Google Scholar
• Chaturvedi NC, et al. Novel process for production of the somatostatin analog, octreotide. Synthesis in solution of peptide fragments and their coupling using the scheme [3+3]+2 WO200303097668. 2003.
   Google Scholar
• Eli Lilly, USA Mayer, Philip J, Zeng YL. Use of trichloroacetimidate linker for peptide synthesis. US0039161. 2004.
   Google Scholar
• Chang chun Lifein Pharmaceutical Co., Ltd., Peop. Rep. ChinaJia Z, Wang E Solid-phase synthesis of octreotide acetate. CN1569890. 2005.
   Google Scholar
• Chemi Spa, Cinisello Balsamo, Italy Cappelletti S, Storace O, Annoni P et al. Process for the formation of disulfide bonds in cyclic peptides. US 20050239695. 2005.
   Google Scholar
• Dalton Chemical Lab IncIarov A, Avrutov I, Lazarowych N, et al. Process for octreotide synthesis. WO087794. 2005.
   Google Scholar
• Wockhardt Ltd, India Singh KKL, Mukarram SMJ, Ashok DA et al. Processes for the preparation of octreotide. WO 2007110765A2. 2007.
   Google Scholar
• Limited USV, IndiaSaksena DL, Pawar DS, et al. An improved process for synthesis of cyclic octapeptide. WO089757. 2010.
   Google Scholar
• ZAO “Farm-Sintez”, RussiaNazarenko AB, Balaev AN, Fedorov VE Method for obtaining cyclic peptide-octreotide. RU2435780. 2010.
   Google Scholar
• Centre National de la Recherche Scientifique (CNRS) Fr Caussil M, Martinez J, Tailhades J, Synthesis of peptide alcohols by solid phase synthesis of depsipeptides and O-N acyl-transfer reaction in solution. EP2270025 and WO2011000848. 2011.
   Google Scholar
• Natco Pharma Limited Kota S, Tallapaneni V, Adibhatla KSBR, et al. Improved process for the preparation of octreotide by solution phase synthesis. WO132505. 2013.
   Google Scholar
• Chemical & Biopharmaceutical Laboratories of Patras S.A. Barlos KK. Solid phase peptide synthesis via side chain attachment. WO098802. 2013.
   Google Scholar
• Mylan Laboratories Ltd Kuppanna A, Dokka MS, Vanjivaka S, et al. Process for the preparation of octreotide acetate. WO046233A2.
   Google Scholar